LymPro JV Partnership before a NAS uplisting? A
Post# of 30028
Posted On: 10/13/2014 11:46:44 AM
LymPro JV Partnership before a NAS uplisting?
As stated previously, what's interesting now is the somewhat suttle change in verbiage regarding a LymPro JV Partnership:
Quote:
"We project a partnership agreement for LymPro will follow shortly after the completion of the LP-002 study , and the Company is weighing strategic options which include a potential ‘spin-out’ of our diagnostics division (which includes LymPro and NuroPro)"
Chairmans Blog 08/10/14
Quote:
"Milestone: LymPro partner validation of analytical performance package (APP) and CLIA certification"
GC Incentive Bonus Milestones filing 10/10/14
I would still very much like to know why tying down a LymPro JV Agreement/Partnership continues to be IMHO, nubulous and visceral - now going late into FY14 without it having happened.
Could it be tied to GC's plan to spin out the Diagnostic's Div. and the possibility that he does not want it encumbered with a contract agreement before then? If so, he hasn't said - and IMHO, this question needs to be posed on Twitter....
Peep's have been trumpeting revenue from Lympro since last year. We're fast approaching FY15, and still have no definitive time line, as the LymPro Partnership continues to remain a float on the infamous AMBS milestone schedule...
Read More: http://investorshangout.com/post/view?id=2127...z3G2Y3n1Wc
As stated previously, what's interesting now is the somewhat suttle change in verbiage regarding a LymPro JV Partnership:
Quote:
"We project a partnership agreement for LymPro will follow shortly after the completion of the LP-002 study , and the Company is weighing strategic options which include a potential ‘spin-out’ of our diagnostics division (which includes LymPro and NuroPro)"
Chairmans Blog 08/10/14
Quote:
"Milestone: LymPro partner validation of analytical performance package (APP) and CLIA certification"
GC Incentive Bonus Milestones filing 10/10/14
I would still very much like to know why tying down a LymPro JV Agreement/Partnership continues to be IMHO, nubulous and visceral - now going late into FY14 without it having happened.
Could it be tied to GC's plan to spin out the Diagnostic's Div. and the possibility that he does not want it encumbered with a contract agreement before then? If so, he hasn't said - and IMHO, this question needs to be posed on Twitter....
Peep's have been trumpeting revenue from Lympro since last year. We're fast approaching FY15, and still have no definitive time line, as the LymPro Partnership continues to remain a float on the infamous AMBS milestone schedule...
Read More: http://investorshangout.com/post/view?id=2127...z3G2Y3n1Wc
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼